SeaStar Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, SeaStar Medical sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
SeaStar Medical: 6 sponsored US clinical trials, 3 recruiting.
SeaStar Medical sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Acute Kidney Injury, with 2 trials.
Upper-quartile sponsor footprint
SeaStar Medical sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
NCT03836482
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
NCT06517810
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NCT05758077
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
NCT04395911
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
NCT01400893
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
NCT01072682
Therapeutic Areas
What is open in the SeaStar Medical pipeline
3 recruiting of 6 indexed (50% open); 2 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute Kidney Injury (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
SeaStar Medical: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
SeaStar Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this SeaStar Medical page
6 registered trials is a research-attention snapshot, not an endorsement of SeaStar Medical or any single study.
- 3 of SeaStar Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Kidney Injury is the condition SeaStar Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Kidney Injury trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
SeaStar Medical pipeline card: 6 registered trials from official public datasets.Report a data error.